Alternatives to Apoha

A University of Cambridge spin-out tackling unmet drug screening needs by combining materials engineering and cell biology.

Developing and industrializing cellulose-based superabsorbent materials as a fossil-free and biodegradable alternative.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Building foundational AI superintelligence to accelerate scientific knowledge discovery and breakthroughs across complex domains.

Global biopharmaceutical company pioneering mRNA-based immunotherapies and vaccines for cancer and infectious diseases.

Biotechnology company leveraging ultracompact CRISPR systems for gene editing therapies and diagnostics.

Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.

A life sciences company that has developed a high-throughput platform for mapping molecular cell architecture at nanoscale resolution.

Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).

Spatial multiomics company developing technologies for single-cell gene expression profiling in intact tissues.

Developing first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.

Leveraging AI and a massive patient tissue dataset to accelerate drug discovery and advance precision medicine.

Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.

Clinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.

Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.

A vertically-integrated procurement platform for the life sciences industry.

A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.

Freenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.

Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).

A global leader in clinical pharmacology and bioanalytical sciences.